DR.DE PAEPE ELSIE,ALGEMENE GENEESKUNDE financials
A multi-period view of the public annual-account figures reported for DR.DE PAEPE ELSIE,ALGEMENE GENEESKUNDE, with comparable measures and links to available source documents.
Company overviewRegistry number
0823306009
Fiscal coverage
2024–2025
Public sources
cbso_bulk
Data updated
Jul 28, 2026
Financial evidence
Latest movements for DR.DE PAEPE ELSIE,ALGEMENE GENEESKUNDE
2025 versus 2024
- Operating line
- €234,042
- EBITDA
- €214,997
- Total assets
- €695,671
- Equity
- €524,511
+9.8%
+12.3%
+13.2%
-0.1%
EBITDA margin +91.9% · Equity ratio +75.4%
Multi-year filings
Source: NBB/CBSOFiled annual accounts by fiscal year
Public regulator-filed figures across 2 years.
Fiscal year | Gross margin | EBITDA | Total assets | Equity | Filing |
|---|---|---|---|---|---|
| 202531 Dec 2025 | €234,042 | €214,997 | €695,671 | €524,511 | - |
| 202431 Dec 2024 | €213,069 | €191,383 | €614,324 | €524,950 | - |
Figures reproduce public filings and may use country-specific accounting definitions. They are not audited by Upswitch.